Raise closed, search for fresh raises on Seedstage

Pittsburgh, PA

AI-powered platform for early detection and management of chronic wounds to improve patient care and reduce healthcare costs.

• Transforming Wound Care: Low-cost, patented solution addressing chronic wounds and disparities in skin health.
• Strong Partnerships: Collaborations with Baylor School of Medicine and corporate distribution partners.
• Proven Prototype: Functional prototype with positive initial patient data demonstrating effectiveness.
• Market Opportunity: $26 billion chronic wound care market with significant growth potential.
• Scalable Model: Razor-blade business approach with recurring revenue from consumable covers.

Rubitection is addressing the significant global healthcare challenge of chronic wounds, such as diabetic foot ulcers and bedsores, through an AI-powered care management platform. Chronic wounds affect over 2 million individuals annually in the U.S., with a disproportionate impact on people of color due to inaccuracies in traditional skin assessments. This leads to a staggering $26 billion in healthcare costs and 60,000 deaths annually. Rubitection’s patented solution, the Rubitect Assessment System, combines a low-cost handheld optical probe with a mobile app to monitor inflammation and provide early intervention. The system is easy to use and delivers reliable, objective results across all skin tones, aiming to become the standard of care in chronic wound management.

With a functional prototype and positive initial patient data, Rubitection is collaborating with clinical partners like Baylor School of Medicine and has received letters of interest from corporate distribution partners. The company’s innovative approach offers a 75% cost advantage over competitors and eliminates the need for specialized training. Beyond chronic wound care, the technology has the potential to address a wide range of skin health issues, including eczema, psoriasis, and surgical infections. Funding will support further development, regulatory milestones, and market entry, driving a scalable business model that combines device sales with recurring revenue from disposable covers. Rubitection’s mission is to empower caregivers and healthcare facilities to improve patient outcomes, reduce costs, and eliminate disparities in skin health monitoring.

Company Info

Rubitection offers an AI-powered system for early detection and management of chronic wounds, aimed at improving patient care and reducing healthcare costs.

Rubitection is developing an AI-powered care management system designed to revolutionize the treatment of chronic wounds such as diabetic foot ulcers and bedsores (pressure injuries). By utilizing a low-cost, easy-to-use handheld optical probe combined with a mobile app, Rubitection enables caregivers to more accurately monitor skin health and track wound progression. The system addresses a critical issue in wound care by providing a more reliable way to detect early signs of inflammation, particularly for people with darker skin tones, where traditional methods fail. The platform is designed to reduce costly mistakes in wound diagnosis, minimize health disparities, and offer an affordable solution to a $26 billion healthcare problem.

Rubitection’s solution has garnered significant attention, with an initial prototype showing positive patient data, two issued patents, and letters of interest from major distribution partners. The company is targeting hospitals and healthcare facilities through a scalable business model, generating both direct sales and recurring revenue from disposable covers used in the monitoring process. With a growing focus on chronic wound management, Rubitection’s AI-driven technology promises to improve patient care, reduce healthcare costs, and set a new standard in wound assessment.